| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $162.8M | +81.9% |
| SG&A Expense | $45.8M | +14.6% |
| Operating Income | -$208.6M | +13.9% |
| Pre-tax Income | -$208.0M | +38.6% |
| Income Tax | $51K | +296.2% |
| Net Income | -$208.0M | +38.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $89.4M | -52.7% |
| Current Assets | $608.5M | +78.2% |
| Total Assets | $608.5M | +78.0% |
| Current Liabilities | $54.1M | +69.1% |
| Total Liabilities | $90.7M | +23.7% |
| Stockholders' Equity | $517.8M | +181.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$157.4M | -57.6% |
| Capital Expenditures | $0 | — |
| Investing Cash Flow | -$353.3M | -225.9% |
| Financing Cash Flow | $410.9M | +13.8% |
| Free Cash Flow | -$157.4M | -57.6% |